Naloxone Protects against Lipopolysaccharide-Induced Neuroinflammation and Microglial Activation via Inhibiting ATP-Sensitive Potassium Channel
Author(s) -
Zhijia Tang,
Xiaobao Shao,
Jun Wu,
Hucheng Chen,
Anyu Zhang,
Fei Xu,
Ping He,
Shiwei Li,
Chunyan Liu,
Yijun Li,
Xue Xue,
Yuan Bin-bin
Publication year - 2021
Publication title -
computational and mathematical methods in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.462
H-Index - 48
eISSN - 1748-6718
pISSN - 1748-670X
DOI - 10.1155/2021/7731528
Subject(s) - neuroinflammation , potassium channel , lipopolysaccharide , (+) naloxone , pharmacology , atp sensitive potassium channel , microglia , chemistry , potassium channel blocker , potassium , neuroscience , medicine , endocrinology , inflammation , biology , biochemistry , antagonist , receptor , glibenclamide , diabetes mellitus , organic chemistry
Aim The aim of this study was to evaluate the anti-inflammatory effects and underlying mechanism of naloxone on lipopolysaccharide- (LPS-) induced neuronal inflammation and microglial activation.Methods LPS-treated microglial BV-2 cells and mice were used to investigate the anti-inflammatory effects of naloxone.Results The results showed that naloxone dose-dependently promoted cell proliferation in LPS-induced BV-2 cells, downregulated the expression of proinflammatory cytokines (TNF- α , IL-1 β , and IL-6) and proinflammatory enzymes iNOS and COX-2 as well as the expression of free radical molecule NO, and reduced the expression of Iba-1-positive microglia in LPS-stimulated BV-2 cells and mouse brain. Moreover, naloxone improved LPS-induced behavior degeneration in mice. Mechanically, naloxone inhibited LPS-induced activation in the ATP-sensitive potassium (KATP) channel. However, the presence of glibenclamide (Glib), an antagonist of KATP channel, ameliorated the suppressive effects of naloxone on inflammation and microglial activation.Conclusion Naloxone prevented LPS-induced neuroinflammation and microglial activation partially through the KATP channel. These findings might highlight the potential of naloxone in neuroinflammation therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom